Biggest News Aggregation in the World
📰 Important Safety News

Page 32 - Important Safety News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Important Safety. Real-time updates on events, politics, business and more.

Genentech's Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment -December 08, 2023 at 11:46 am EST

– Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date – – Long-term data also showed continued benefit in...
South San Francisco United States Roche Group Immunogen Inc Prescribing Information Most Important Safety Information

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Genentech's Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment

– Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date –– Long-term data also showed continued benefit in invasive disease-free survival for adjuvant Kadcyla compared to Herceptin in this study –– These data will be presented as an or...
South San Francisco United States San Antonio Bruno Eschli Levi Garraway Loren Kalm

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science